Skip to main content

Closed

CCCC: C4 Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-326.6%

ROIC-36.9%

Financially safe

Stretched

Debt / equity0.25×

Interest coverage0.0×

Current ratio9.00×

C4 Therapeutics, Inc.

CCCCNASDAQ Global Select·USD·Closed

C4 Therapeutics, Inc.

CCCCNASDAQ·USD·Closed

$3.48

−4.92%

$3.48

−$0.18 (4.92%)

52W Range

51thpctl

Volume

0.59×avg

Mkt Cap

384.77MUSD

P/E

-3.1TTM

Div Yield

–ann

52W Range

51thpctl

Volume

0.59×avg

Market Cap

384.77MUSD

P/E Ratio

-3.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings